Ticker >

Medi-Caps share price

Medi-Caps Ltd.

NSE: MEDICAPS BSE: 523144 SECTOR: Chemicals  16k   73   11

44.33
+0.40 (0.91%)
BSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 45.99

Today's Low

₹ 44.06

52 Week High

₹ 63.49

52 Week Low

₹ 30.62

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

55.28 Cr.

Enterprise Value

55.24 Cr.

No. of Shares

1.25 Cr.

P/E

17.23

P/B

0.85

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  52.16

CASH

0.04 Cr.

DEBT

0 Cr.

Promoter Holding

50.13 %

EPS (TTM)

₹  2.57

Sales Growth

0%

ROE

0.42 %

ROCE

0.42%

Profit Growth

442.02 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year∞%
3 Year-78.98%
5 Year-66.02%

Profit Growth

1 Year485.53%
3 Year26.36%
5 Year-23.62%

ROE%

1 Year0.42%
3 Year0.1%
5 Year-2.38%

ROCE %

1 Year0.42%
3 Year0.11%
5 Year-2.32%

Debt/Equity

0

Price to Cash Flow

-21.29

Interest Cover Ratio

78.5151515151515

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 50.13 0
Sep 2023 50.13 0
Jun 2023 50.13 0
Mar 2023 50.13 0
Dec 2022 50.13 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 26.6374169564868% for the Past 3 years.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.0389746867254013.
  • Company has a healthy liquidity position with current ratio of 194.930769230769.
  • The company has a high promoter holding of 50.13%.

 Limitations

  • The company has shown a poor revenue growth of -78.9805540105847% for the Past 3 years.
  • Company has a poor ROE of 0.101900054074293% over the past 3 years.
  • Company has a poor ROCE of 0.114025835689777% over the past 3 years
  • Company has high debtor days of 8070.71569595262.
  • Company has negative cash flow from operations of -2.5962.
  • Tax rate is low at -0.547302580140735.
  • The company has a low EBITDA margin of -71.9739175679361% over the past 5 years.
  • The company is trading at a high PE of 17.23.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0.01 0.06 0.02 2.13 3.05
Total Expenditure 0.09 0.1 0.37 0.16 0.87
Operating Profit -0.08 -0.03 -0.35 1.97 2.17
Other Income 0 0.03 0.01 0 0
Interest 0 0 0 0 0
Depreciation 0.02 0.02 0.04 0.04 0.04
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.1 -0.03 -0.38 1.93 2.14
Tax 0 0 0 0 0.45
Profit After Tax -0.1 -0.03 -0.38 1.93 1.69
Adjusted EPS (Rs) -0.08 -0.02 -0.31 1.55 1.35

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 21.62 10.91 0 0 0.1
Total Expenditure 21.66 19.98 0 0.56 0.39
Operating Profit -0.04 -9.07 0 -0.56 -0.29
Other Income 1.14 1.12 0 0.61 0.64
Interest 0.04 0.01 0 0.01 0
Depreciation 0.35 0.36 0 0.09 0.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.71 -8.32 0 -0.06 0.26
Tax 0.12 0.01 -0.01 0.01 0
Net Profit 0.59 -8.33 -0.11 -0.04 0.15
Adjusted EPS (Rs.) 0.47 -6.68 0 -0.06 0.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 12.47 12.47 12.47 12.47 12.47
Total Reserves 55.04 47.38 48.5 48.82 48.64
Borrowings 0.06 0 0 0 0
Other N/C liabilities 1.7 0.68 0.56 0.44 0.44
Current liabilities 4.51 1.03 1.11 0.08 0.08
Total Liabilities 73.78 61.55 62.64 61.81 61.63
Assets
Net Block 3.91 3.63 3.26 2.78 2.46
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 46.95 45.47 43.02 43.91 43.91
Loans & Advances 0.45 0.05 0.05 0.05 0.05
Other N/C Assets 0 0 1.08 0 0
Current Assets 22.47 12.4 15.23 15.07 15.2
Total Assets 73.78 61.55 62.64 61.81 61.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.71 -8.32 -0.12 -0.06 0.26
Adjustment 0.35 0.94 1.57 0.58 -0.28
Changes in Assets & Liabilities 0.37 6.45 0.79 -1.47 -2.57
Tax Paid -0.1 0 0 0 0
Operating Cash Flow 1.33 -0.92 2.24 -0.95 -2.6
Investing Cash Flow -1.19 -0.4 -2.19 1.01 1.85
Financing Cash Flow -0.05 -0.06 -0.06 0 0
Net Cash Flow 0.09 -1.38 -0.02 0.06 -0.75

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 50.13 50.13 50.13 50.13 50.13
alok k garg 25.87 25.87 25.87 25.87 25.87
kusum mittal 0.08 0.08 0.08 0.08 0.08
manisha garg 21.61 21.61 21.61 21.61 21.61
nirmala anantram mittal 0.03 0.03 0.03 0.03 0.03
ramesh chandra mittal 0.08 0.08 0.08 0.08 0.08
trapti investments llp 2.46 2.46 2.46 2.46 2.46
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 49.87 49.87 49.87 49.87 49.87
dheeraj kumar lohia 1.94 2.14 2.31 2.55 3.35
investor education and pr... 0.65 - - - 0.65
punit kumar jain 1.03 1.03 1.03 1.01 1.01
sangeetha s 5.57 5.57 5.57 5.57 5.57
gopal krishna maheshwari 1.26 1.26 1.26 1.01 -
investor education and pr... - 0.65 0.65 0.65 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Medi-Caps - Quaterly Results8 Feb 2024, 4:54PM Medi-Caps - Quaterly Results8 Feb 2024, 4:54PM Medi-Caps - Quaterly Results8 Feb 2024, 4:54PM Medi-Caps informs about certificate9 Jan 2024, 4:31PM Medi-Caps informs about closure of trading window28 Dec 2023, 11:14AM Medi-Caps informs about certificate10 Oct 2023, 2:11PM Medi-Caps submits standalone and consolidated un-audited financial results 11 Aug 2023, 5:08PM Medi-Caps - Quaterly Results11 Aug 2023, 4:11PM Medi-Caps - Quaterly Results23 May 2023, 5:12PM Medi-Caps - Quaterly Results23 May 2023, 5:12PM Medi-Caps informs about PCS certificate21 Apr 2023, 4:32PM Medi-Caps informs about updates27 Feb 2023, 3:02PM Medi-Caps - Quaterly Results9 Feb 2023, 4:28PM Medi-Caps - Quaterly Results9 Feb 2023, 4:28PM Medi-Caps - Quaterly Results9 Feb 2023, 4:28PM Medi-Caps - Quaterly Results10 Nov 2022, 6:40PM Medi-Caps informs about compliance certificate7 Oct 2022, 5:06PM Medi-Caps informs about AGM proceedings29 Sep 2022, 12:32PM Medi-Caps informs about newspaper advertisement23 Aug 2022, 4:51PM Medi-Caps - Quaterly Results4 Aug 2022, 4:41PM Medi-Caps - Quaterly Results4 Aug 2022, 4:41PM Medi-Caps - Quaterly Results4 Aug 2022, 4:41PM Medi-Caps informs about certificate7 Jul 2022, 5:00PM Medi-Caps informs about newspaper advertisement27 May 2022, 4:35PM Medi-Caps - Quaterly Results25 May 2022, 5:22PM Medi-Caps - Quaterly Results25 May 2022, 5:22PM Medi-Caps informs about disclosure16 Apr 2022, 3:30PM Medi-Caps informs about compliance certificate11 Apr 2022, 4:25PM Medi-Caps informs about trading window closure30 Mar 2022, 2:10PM Medi-Caps informs about disclosure25 Mar 2022, 3:14PM Medi-Caps informs about change in the last name of the CS cum Co26 Feb 2022, 4:52PM Medi-Caps - Quaterly Results10 Feb 2022, 4:20PM Medi-Caps - Quaterly Results10 Feb 2022, 4:20PM Medi-Caps informs about newspaper advertisement12 Nov 2021, 4:18PM Medi-Caps informs about AGM proceedings29 Sep 2021, 3:17PM Medi-Caps to consider un-audited quarterly financial results30 Jan 2021, 12:17PM Medi-Caps informs about press release30 Oct 2020, 4:41PM

Medi-Caps Stock Price Analysis and Quick Research Report. Is Medi-Caps an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Medi-Caps has a PE ratio of 17.2315944958408 which is high and comparatively overvalued .

  • Share Price: - The current share price of Medi-Caps is Rs 44.33. One can use valuation calculators of ticker to know if Medi-Caps share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Medi-Caps has ROA of 0.416751734575163 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Medi-Caps has a Current ratio of 194.930769230769 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Medi-Caps has a ROE of 0.42027688926472 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Medi-Caps has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Medi-Caps has an Inventory turnover ratio of 0 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Medi-Caps has reported revenue growth of 0 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Medi-Caps for the current financial year is -289.437314906219 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Medi-Caps is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Medi-Caps
X